Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Adele Heitzmann"'
Autor:
Frédéric Schmidt, Xavier Sastre-Garau, Cornélie Batisse, Sebastian Amigorena, Rafik Ait Sarkouh, Pascale Hubert, Eliane Piaggio, Eduardo Osinaga, Philippe De La Rochere, Nathalie Amzallag, Pablo Oppezzo, Christine Sedlik, Adele Heitzmann, Otto Pritsch, Sophie Viel
Publikováno v:
OncoImmunology
OncoImmunology, Taylor & Francis, 2016, 5 (7), pp.e1171434. ⟨10.1080/2162402X.2016.1171434⟩
OncoImmunology, 2016, 5 (7), pp.e1171434. ⟨10.1080/2162402X.2016.1171434⟩
OncoImmunology, Taylor & Francis, 2016, 5 (7), pp.e1171434. 〈10.1080/2162402X.2016.1171434〉
OncoImmunology, Taylor & Francis, 2016, 5 (7), pp.e1171434. ⟨10.1080/2162402X.2016.1171434⟩
OncoImmunology, 2016, 5 (7), pp.e1171434. ⟨10.1080/2162402X.2016.1171434⟩
OncoImmunology, Taylor & Francis, 2016, 5 (7), pp.e1171434. 〈10.1080/2162402X.2016.1171434〉
International audience; Antibody-drug conjugates (ADC), combining the specificity of tumor recognition by monoclonal antibodies (mAb) and the powerful cytotoxicity of anticancer drugs, are currently under growing interest and development. Here, we st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2e732de91544bc7240dc4c62c88aee3
https://hal.archives-ouvertes.fr/hal-02137864
https://hal.archives-ouvertes.fr/hal-02137864
Autor:
André Nicolas, Otto Pritsch, Sophie Viel, Sebastian Amigorena, Pablo Oppezzo, Adele Heitzmann, Xavier Sastre-Garau, Pascale Hubert, Eduardo Osinaga
Publikováno v:
Cancer Research
Cancer Research, American Association for Cancer Research, 2011, 71 (15), pp.5134-43. ⟨10.1158/0008-5472.CAN-10-4222⟩
Cancer Research; Vol 71
Cancer Research, American Association for Cancer Research, 2011, 71 (15), pp.5134-43. 〈10.1158/0008-5472.CAN-10-4222〉
Cancer Research, American Association for Cancer Research, 2011, 71 (15), pp.5134-43. ⟨10.1158/0008-5472.CAN-10-4222⟩
Cancer Research; Vol 71
Cancer Research, American Association for Cancer Research, 2011, 71 (15), pp.5134-43. 〈10.1158/0008-5472.CAN-10-4222〉
Antibody-dependent cell cytotoxicity (ADCC) plays a critical role in monoclonal antibody (mAb)-mediated cancer therapy. ADCC, however, has not been directly shown in vivo but inferred from the requirement for IgG Fc receptors (FcγR) in tumor rejecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::332f9cf0fa60a2116b3cc261a15b7592
https://hal-riip.archives-ouvertes.fr/pasteur-00685062
https://hal-riip.archives-ouvertes.fr/pasteur-00685062